Lexeo Therapeutics, Inc.'s total assets for Q4 2024 were $146.94M, a decrease of -15.49% from the previous quarter. LXEO total liabilities were $30.10M for the fiscal quarter, a -12.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.